The best question is not if and where? It’s why

The best question is not if and where? It’s why did we need receptor occupancy?

Why were we required to have receptor occupancy when it wasn’t part of the trial protocol? That’s the real needed question.

The trial wasn’t designed with RO and it was looked upon as a delay tactic to ask for something we started to gather as general information after the trial was already in motion. If that is true and we misspoke (should of said nothing about it) about having that information available and then they the FDA demanded it and didn’t like it after the fact that it wasn’t performed in the way they would of liked to have seen it and we should spend a year recreating the information for something that wasn’t even required in the original trial. What’s that say?

I would look at that as strictly a delay tactic and slow playing us.

Now I don’t know if everything I said or repeated was gospel. It’s what I have learned from this board here and a from a very good source. I will believe what I have learned. Without revealing that credible source.